How a Dutch AI Startup is Quietly Fixing a Global Hearing Care Crisis

Jan de Vries · 2026-08-28

There's a quiet revolution happening in hearing care, and it's starting in a city you might not expect. Maastricht-based startup Clementine just secured $2 million in Seed funding. This isn't just another tech funding story. It's about addressing a massive, silent problem that affects billions. ### The Problem: A Staggering Gap in Care Let's talk numbers for a second, because they're shocking. Hearing loss impacts roughly 1.5 billion people worldwide. That's a huge number, but here's the kicker—nearly 80% of those people never get any treatment. And for those who finally do seek help? They typically wait over eight years. Eight years of struggling, of missing conversations, of disconnecting. The system is broken, and Clementine's founder, Vince van de Weijer, saw a way to fix it using a surprising combination: AI and behavioral science. ### Meet Matthew, The AI Agent That Never Sleeps The core of Clementine's platform is an AI hearing care agent named Matthew. Think of Matthew as a compassionate, infinitely patient guide. He's available 24/7 to answer questions without judgment, educate potential patients, and gently guide them toward the right care. For someone anxious about hearing loss, that first step is the hardest. Matthew removes the barrier. As Vince puts it perfectly: "Clinics don't need more leads; they need better conversations at the right moment. Matthew ensures no patient inquiry goes unanswered." This is the real value. It's not about flashy tech for tech's sake. It's about creating a judgment-free, always-available starting point for people long before they're ready to walk into a clinic. For the clinics themselves, Matthew automates the initial administrative grind, translating inquiries into actual bookings and freeing up staff for more complex tasks. ### Who's Backing This Vision? The $2 million Seed round was led by Healthy.Capital, an Amsterdam-based HealthTech investor with a sharp eye for impactful companies. They've backed other innovators like Pharmi and OpenUp. Douwe Jippes, managing partner at Healthy.Capital, highlighted why they invested: > "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with healthcare." That last part is key—*scale globally*. This funding comes at a strategic time, right after Clementine expanded its North American footprint through a partnership with Zoolstra, a marketing agency serving hearing clinics across the United States and Canada. ### What's Next for ClementineAI? So, where does that $2 million go? The plan is twofold: - Deepen the core AI capabilities, making Matthew even more intuitive and helpful. - Expand partnerships beyond traditional hearing clinics to optical retailers and other healthcare organizations, meeting people where they already are. Founded just this year, Clementine (or ClementineAI) calls itself the world's first AI hearing activation platform built specifically for this industry. That's a bold claim, but their approach—pairing technology with a deep understanding of human hesitation—might just be the key to unlocking care for millions. It's a reminder that sometimes, the most powerful solutions come from listening to what people aren't saying, and building a bridge for them to cross when they're ready.